Showing results (381-390 of 447) with videos related to

Sort By:
Pageof 45
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 18, 2014
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative studyN de Bortoli, G Guidi, I Martinucci, et al.
Journal of Endocrinological Investigation|October 12, 2011
Sporadic and hereditary primary hyperparathyroidismJ Pepe, C Cipriani, R Pilotto, et al.
British Journal of Pharmacology|March 7, 2014
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrationsI Hassan-Mohamed, C Giorgio, M Incerti, et al.
Sports Medicine (Auckland, N.Z.)|January 31, 2016
Sports Eligibility After Risk Assessment and Treatment in Children with Asymptomatic Ventricular Pre-excitationCorrado Di Mambro, F Drago, M Milioni, et al.
Cancer|September 26, 2001
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trialM A Socinski, J G Rosenman, J Halle, et al.
Clinical Spine Surgery|April 3, 2020
Update on Spinal Cord Injury ManagementGlenn S Russo, John J Mangan, Matthew S Galetta, et al.
Science Advances|February 13, 2019
Laser-writable high-k dielectric for van der Waals nanoelectronicsN Peimyoo, M D Barnes, J D Mehew, et al.
Journal of Clinical Orthopaedics and Trauma|September 28, 2017
Tibial shaft fracture: A large-scale study defining the injured population and associated injuriesNidharshan S Anandasivam, Glenn S Russo, Matthew S Swallow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2010
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancerJ P Arnoletti, A Frolov, M Eloubeidi, et al.
Pageof 45